Skip to main content
  • New Permanent Pacemaker After TAVR Does Not Impact 5-Year Clinical Outcomes: Registry Data

    New permanent pacemaker (PPM) within 30 days of transcatheter aortic valve replacement (TAVR), remains a frequent complication in patients with aortic stenosis (AS), with identifiable clinical, electrocardiogram (ECG) and imaging predictors. However, new PPM is not associated with worse 5-year clinical outcomes, including mortality, reports a new analysis of registry data.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details